Skip to main content
Top
Published in: Journal of Translational Medicine 1/2018

Open Access 01-12-2018 | Research

Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study

Authors: Ashkan Hashemi, Sormeh Nourbakhsh, Samaneh Asgari, Mohammadhassan Mirbolouk, Fereidoun Azizi, Farzad Hadaegh

Published in: Journal of Translational Medicine | Issue 1/2018

Login to get access

Abstract

Background

To explore the association between systolic and diastolic blood pressure (SBP and DBP respectively) and pulse pressure (PP) with cardiovascular disease (CVD) and mortality events among Iranian patients with prevalent CKD.

Methods

Patients [n = 1448, mean age: 60.9 (9.9) years] defined as those with estimated glomerular filtration rate < 60 ml/min/1.73 m2, were followed from 31 January 1999 to 20 March 2014. Multivariable Cox proportional hazard models were applied to examine the associations between different components of BP with outcomes.

Results

During a median follow-up of 13.9 years, 305 all-cause mortality and 317 (100 fatal) CVD events (among those free from CVD, n = 1232) occurred. For CVD and CV-mortality, SBP and PP showed a linear relationship, while a U-shaped relationship for DBP was observed with all outcomes. Considering 120 ≤ SBP < 130 as reference, SBP ≥ 140 mmHg was associated with the highest hazard ratio (HR) for CVD [1.68 (1.2–2.34)], all-cause [1.72 (1.19–2.48)], and CV-mortality events [2.21 (1.16–4.22)]. Regarding DBP, compared with 80 ≤ DBP < 85 as reference, the level of ≥ 85 mmHg increased risk of CVD and all-cause mortality events; furthermore, DBP < 80 mmHg was associated with significant HR for CVD events [1.55 (1.08–2.24)], all-cause [1.68 (1.13–2.5)] and CV-mortality events [3.0 (1.17–7.7)]. Considering PP, the highest HR was seen in participants in the 4th quartile for all outcomes of interest; HRs for CVD events [1.92 (1.33–2.78)], all-cause [1.71 (1.11–2.63)] and CV-mortality events [2.22 (1.06–4.64)].

Conclusions

Among patients with CKD, the lowest risk of all-cause and CV-mortality as well as incident CVD was observed in those with SBP < 140, 80 ≤ DBP < 85 and PP < 64 mmHg.
Literature
1.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.CrossRefPubMed
2.
go back to reference Wright J, Hutchison A. Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag. 2009;5:713–22.PubMedPubMedCentral Wright J, Hutchison A. Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag. 2009;5:713–22.PubMedPubMedCentral
3.
go back to reference Norris KC, Nicholas SB. Strategies for controlling blood pressure and reducing cardiovascular disease risk in patients with chronic kidney disease. Ethn Dis. 2015;25(4):515–20.CrossRefPubMedPubMedCentral Norris KC, Nicholas SB. Strategies for controlling blood pressure and reducing cardiovascular disease risk in patients with chronic kidney disease. Ethn Dis. 2015;25(4):515–20.CrossRefPubMedPubMedCentral
4.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure; the JNC 7 report. JAMA. 2003;289(19):2560.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure; the JNC 7 report. JAMA. 2003;289(19):2560.CrossRefPubMed
5.
go back to reference James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.CrossRefPubMed James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.CrossRefPubMed
6.
go back to reference Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, Miller EP, Polonsky T, Thompson-Paul AM, Vupputuri S. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):2176–98.CrossRefPubMed Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, Miller EP, Polonsky T, Thompson-Paul AM, Vupputuri S. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):2176–98.CrossRefPubMed
7.
go back to reference Bansal N, McCulloch CE, Lin F, Robinson-Cohen C, Rahman M, Kusek JW, et al. Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney. Kidney Int. 2016;90:1348–56.CrossRefPubMedPubMedCentral Bansal N, McCulloch CE, Lin F, Robinson-Cohen C, Rahman M, Kusek JW, et al. Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney. Kidney Int. 2016;90:1348–56.CrossRefPubMedPubMedCentral
8.
go back to reference SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef
10.
go back to reference Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease. Ann Intern Med. 2013;159(4):233.CrossRefPubMedPubMedCentral Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease. Ann Intern Med. 2013;159(4):233.CrossRefPubMedPubMedCentral
11.
go back to reference Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, et al. Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. JAMA Intern Med. 2014;174(9):1442–9.CrossRefPubMedPubMedCentral Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, et al. Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. JAMA Intern Med. 2014;174(9):1442–9.CrossRefPubMedPubMedCentral
12.
go back to reference Weiss JW, Peters D, Yang X, Petrik A, Smith DH, Johnson ES, et al. Systolic bp and mortality in older adults with CKD. Clin J Am Soc Nephrol. 2015;10(9):1553–9.CrossRefPubMedPubMedCentral Weiss JW, Peters D, Yang X, Petrik A, Smith DH, Johnson ES, et al. Systolic bp and mortality in older adults with CKD. Clin J Am Soc Nephrol. 2015;10(9):1553–9.CrossRefPubMedPubMedCentral
13.
go back to reference Kovesdy CP, Alrifai A, Gosmanova EO, Lu JL, Canada RB, Wall BM, et al. Age and outcomes associated with BP in patients with incident CKD. Clin J Am Soc Nephrol. 2016;11(5):821–31.CrossRefPubMedPubMedCentral Kovesdy CP, Alrifai A, Gosmanova EO, Lu JL, Canada RB, Wall BM, et al. Age and outcomes associated with BP in patients with incident CKD. Clin J Am Soc Nephrol. 2016;11(5):821–31.CrossRefPubMedPubMedCentral
14.
go back to reference Palit S, Chonchol M, Cheung AK, Kaufman J, Smits G, Kendrick J. Association of BP with death, cardiovascular events, and progression to chronic dialysis in patients with advanced kidney disease. Clin J Am Soc Nephrol. 2015;10(6):934–40.CrossRefPubMedPubMedCentral Palit S, Chonchol M, Cheung AK, Kaufman J, Smits G, Kendrick J. Association of BP with death, cardiovascular events, and progression to chronic dialysis in patients with advanced kidney disease. Clin J Am Soc Nephrol. 2015;10(6):934–40.CrossRefPubMedPubMedCentral
15.
go back to reference Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS ONE. 2012;7(9):e45304.CrossRefPubMedPubMedCentral Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS ONE. 2012;7(9):e45304.CrossRefPubMedPubMedCentral
16.
go back to reference Bozorgmanesh M, Hadaegh F, Mehrabi Y, Azizi F. A point-score system superior to blood pressure measures alone for predicting incident hypertension: Tehran Lipid and Glucose Study. J Hypertens. 2011;29(8):1486–93.CrossRefPubMed Bozorgmanesh M, Hadaegh F, Mehrabi Y, Azizi F. A point-score system superior to blood pressure measures alone for predicting incident hypertension: Tehran Lipid and Glucose Study. J Hypertens. 2011;29(8):1486–93.CrossRefPubMed
17.
go back to reference Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran lipid and glucose study. PLoS ONE. 2014;9(7):e102563.CrossRefPubMedPubMedCentral Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran lipid and glucose study. PLoS ONE. 2014;9(7):e102563.CrossRefPubMedPubMedCentral
18.
go back to reference Turk-Adawi K, Sarrafzadegan N, Fadhil I, Taubert K, Sadeghi M, Wenger NK, et al. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden. Nat Rev Cardiol. 2017;15(2):106–19.CrossRefPubMed Turk-Adawi K, Sarrafzadegan N, Fadhil I, Taubert K, Sadeghi M, Wenger NK, et al. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden. Nat Rev Cardiol. 2017;15(2):106–19.CrossRefPubMed
19.
go back to reference Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5.CrossRefPubMedPubMedCentral Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5.CrossRefPubMedPubMedCentral
20.
go back to reference WHO MONICA Project. MONICA Manual, Part III, Section 1: Population survey data component. WHO MONICA Project. MONICA Manual, Part III, Section 1: Population survey data component.
21.
go back to reference Azizi F, Rahmani M, Emami H, Mirmiran PA, Hajipour R, Madjid M, Ghanbili J, Ghanbarian A, Mehrabi J, Saadat N, Salehi P. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Sozial-und Präventivmedizin. 2002;47(6):408–26.CrossRefPubMed Azizi F, Rahmani M, Emami H, Mirmiran PA, Hajipour R, Madjid M, Ghanbili J, Ghanbarian A, Mehrabi J, Saadat N, Salehi P. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Sozial-und Präventivmedizin. 2002;47(6):408–26.CrossRefPubMed
22.
go back to reference Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9(1):44.CrossRefPubMedPubMedCentral Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9(1):44.CrossRefPubMedPubMedCentral
23.
go back to reference Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD study equation for estimated GFR: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2010;55(4):648–59.CrossRefPubMedPubMedCentral Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD study equation for estimated GFR: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2010;55(4):648–59.CrossRefPubMedPubMedCentral
24.
go back to reference Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–47.CrossRefPubMed Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–47.CrossRefPubMed
25.
go back to reference American Diabetes Association. Standards of medical care in diabetes—2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97–111.CrossRefPubMedCentral American Diabetes Association. Standards of medical care in diabetes—2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97–111.CrossRefPubMedCentral
26.
go back to reference Chalise P, Chicken E, McGee D. Time scales in epidemiological analysis: an empirical comparison. 2009:1–13. Chalise P, Chicken E, McGee D. Time scales in epidemiological analysis: an empirical comparison. 2009:1–13.
27.
go back to reference Robles NR, Hernandez-Gallego R, Fici F, Grassi G. Does a blood pressure J curve exist for patients with chronic kidney disease? J Clin Hypertens. 2017;19(8):764–70.CrossRef Robles NR, Hernandez-Gallego R, Fici F, Grassi G. Does a blood pressure J curve exist for patients with chronic kidney disease? J Clin Hypertens. 2017;19(8):764–70.CrossRef
29.
go back to reference Peralta CA, Norris KC, Li S, Chang TI, Tamura MK, Jolly SE, et al. Blood pressure components and end-stage renal disease in persons with chronic kidney disease. Arch Intern Med. 2012;172(1):41.CrossRefPubMedPubMedCentral Peralta CA, Norris KC, Li S, Chang TI, Tamura MK, Jolly SE, et al. Blood pressure components and end-stage renal disease in persons with chronic kidney disease. Arch Intern Med. 2012;172(1):41.CrossRefPubMedPubMedCentral
30.
go back to reference Winston GJ, Palmas W, Lima J, Polak JF, Bertoni AG, Burke G, et al. Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Hypertens. 2013;26(5):636–42.CrossRefPubMedPubMedCentral Winston GJ, Palmas W, Lima J, Polak JF, Bertoni AG, Burke G, et al. Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Hypertens. 2013;26(5):636–42.CrossRefPubMedPubMedCentral
31.
go back to reference O’Rourke M, Frohlich ED. Pulse pressure: is it a clinically useful risk factor? Hypertension. 1999;34:372–4.CrossRefPubMed O’Rourke M, Frohlich ED. Pulse pressure: is it a clinically useful risk factor? Hypertension. 1999;34:372–4.CrossRefPubMed
32.
go back to reference Peralta CA, Shlipak MG, Wassel-Fyr C, Bosworth H, Hoffman B, Martins S, et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension. 2007;50(3):474–80.CrossRefPubMed Peralta CA, Shlipak MG, Wassel-Fyr C, Bosworth H, Hoffman B, Martins S, et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension. 2007;50(3):474–80.CrossRefPubMed
33.
go back to reference Ladhani M, Craig JC, Irving M, Clayton PA, Wong G. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2016;32(3):439–49. Ladhani M, Craig JC, Irving M, Clayton PA, Wong G. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2016;32(3):439–49.
34.
go back to reference Banack HR, Stokes A. The ‘obesity paradox’ may not be a paradox at all. Int J Obes. 2017;41:1162–3.CrossRef Banack HR, Stokes A. The ‘obesity paradox’ may not be a paradox at all. Int J Obes. 2017;41:1162–3.CrossRef
35.
go back to reference Kramer H, Gutiérrez OM, Judd SE, Muntner P, Warnock DG, Tanner RM, Panwar B, Shoham DA, McClellan W. Waist circumference, body mass index, and ESRD in the REGARDS (reasons for geographic and racial differences in stroke) study. Am J Kidney Dis. 2016;67(1):62–9.CrossRefPubMed Kramer H, Gutiérrez OM, Judd SE, Muntner P, Warnock DG, Tanner RM, Panwar B, Shoham DA, McClellan W. Waist circumference, body mass index, and ESRD in the REGARDS (reasons for geographic and racial differences in stroke) study. Am J Kidney Dis. 2016;67(1):62–9.CrossRefPubMed
36.
go back to reference Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–8.CrossRefPubMed Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–8.CrossRefPubMed
37.
go back to reference Clark CE, Taylor RS, Shore AC, Ukoumunne OC, Campbell JL. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012;379(9819):905–14.CrossRefPubMed Clark CE, Taylor RS, Shore AC, Ukoumunne OC, Campbell JL. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012;379(9819):905–14.CrossRefPubMed
Metadata
Title
Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study
Authors
Ashkan Hashemi
Sormeh Nourbakhsh
Samaneh Asgari
Mohammadhassan Mirbolouk
Fereidoun Azizi
Farzad Hadaegh
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2018
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-018-1603-7

Other articles of this Issue 1/2018

Journal of Translational Medicine 1/2018 Go to the issue